|
|
||||||||
From Unité INSERM U342 (Dr. Aubourg) and the Departments of Pediatric Neurology (Drs. Aubourg, Lemaitre, and Mayer) and Pediatric Radiology (Drs. Adamsbaum and Kalifa), HBpital Saint-Vincent de Paul, Paris; and the Department of Neurophysiology (Drs. Lavallard-Rousseau and Boureau), Hôpital SaintAntoine, Paris, France.
We describe the neurophysiologic abnormalities in 17 patients with clinical adrenomyeloneuropathy (AMN), an adult phenotype of X-linked adrenoleukodystrophy (ALD). These abnormalities also allowed the early recognition of the AMN phenotype in three asymptomatic boys with biochemically proven ALD. In 14/16 adult AMN patients, there were cerebral white matter abnormalities on MRI which were severe and comparable with cerebral ALD in four of the patients.
Address correspondence and reprint requests to Dr. P. Aubourg, Unité INSERM U342, Hôpital Saint-Vincent de Paul, 82 avenue Denfert Rochereau, 75014 Paris, France.
Received March 28, 1991. Accepted for publication in final form June 11, 1991.
This article has been cited by other articles:
![]() |
M. Spurek, R. Taylor-Gjevre, S. Van Uum, and H. M. Khandwala Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis Can. Med. Assoc. J., October 26, 2004; 171(9): 1073 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Barth, C. B.L.M. Majoie, J. Gootjes, R. J.A. Wanders, H. R. Waterham, M. S. van der Knaap, J. B.C. de Klerk, J. Smeitink, and B. T. Poll-The Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival Neurology, February 10, 2004; 62(3): 439 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Loes, A. Fatemi, E. R. Melhem, N. Gupte, L. Bezman, H. W. Moser, and G. V. Raymond Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy Neurology, August 12, 2003; 61(3): 369 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Burns, M. M. Ryan, B. Darras, and H. R. Jones Jr Current Therapeutic Strategies for Patients With Polyneuropathies Secondary to Inherited Metabolic Disorders Mayo Clin. Proc., July 1, 2003; 78(7): 858 - 868. [Abstract] [PDF] |
||||
![]() |
F. Barkhof, A. Verrips, P. Wesseling, M. S. van der Knaap, B. G. M. van Engelen, F. J. M. Gabreëls, A. Keyser, R. A. Wevers, and J. Valk Cerebrotendinous Xanthomatosis: The Spectrum of Imaging Findings and the Correlation with Neuropathologic Findings Radiology, December 1, 2000; 217(3): 869 - 876. [Abstract] [Full Text] |
||||
![]() |
D. Restuccia, V. D. Lazzaro, M. Valeriani, A. Oliviero, D. L. Pera, C. Barba, M. Cappa, E. Bertini, M. D. Capua, and P. Tonali Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy Neurology, March 1, 1999; 52(4): 810 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M van Geel, J. Assies, R. J A Wanders, and P. G Barth X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy J. Neurol. Neurosurg. Psychiatry, July 1, 1997; 63(1): 4 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aubourg, C. Adamsbaum, M.-C. Lavallard-Rousseau, F. Rocchiccioli, N. Cartier, I. Jambaque, C. Jakobezak, A. Lemaitre, F. Boureau, C. Wolf, et al. A Two-Year Trial of Oleic and Erucic Acids ("Lorenzo's Oil") as Treatment for Adrenomyeloneuropathy N. Engl. J. Med., September 9, 1993; 329(11): 745 - 752. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |